Yang Xue, Xiao Xiang, Wang Hailian, Li Yi, Wang Li, Li Guisen, Deng Shaoping
Renal Division and Institute of Nephrology, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Southwest Medical University, Luzhou 646000, China.
Evid Based Complement Alternat Med. 2018 Apr 11;2018:3450141. doi: 10.1155/2018/3450141. eCollection 2018.
The aim of the study was to investigate the protective effect of Danhong injection (DHI) on diabetic kidney disease and explore the potential mechanisms. Diabetic kidney disease was induced by unilateral nephrectomy, high-fat diet, and streptozotocin. After DHI administration, the renal function deterioration, 24-hour total urine protein excretion, and elevated serum lipid levels were reversed to some extent, and the renal pathological damage was also ameliorated. The KEGG pathway enrichment analysis demonstrated that the PPAR signal pathway was significantly upregulated in DH group. And the increased expressions of PPAR and UCP-1 were confirmed by immunohistochemistry, whereas the p38MAPK was significantly decreased. These data show that DHI could delay the progress of DKD, and the effect might be achieved in part by activating the PPAR signaling pathway.
本研究旨在探讨丹红注射液(DHI)对糖尿病肾病的保护作用,并探索其潜在机制。通过单侧肾切除、高脂饮食和链脲佐菌素诱导建立糖尿病肾病模型。给予DHI后,肾功能恶化、24小时尿总蛋白排泄量及血脂水平升高均有一定程度的逆转,肾脏病理损伤也得到改善。KEGG通路富集分析表明,DH组PPAR信号通路显著上调。免疫组化证实PPAR和UCP-1表达增加,而p38MAPK显著降低。这些数据表明,DHI可延缓糖尿病肾病的进展,其作用可能部分通过激活PPAR信号通路实现。